• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER PICCOLO OCCLUDER; OCCLUDER, PATENT DUCTUS, ARTERIOSUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER PICCOLO OCCLUDER; OCCLUDER, PATENT DUCTUS, ARTERIOSUS Back to Search Results
Model Number 9-PDAP-04-04-L
Device Problems Migration or Expulsion of Device (1395); Off-Label Use (1494); Obstruction of Flow (2423)
Patient Problems Vasoconstriction (2126); Obstruction/Occlusion (2422)
Event Type  Injury  
Manufacturer Narrative
An event of migration and protrusion into the aorta of the 4-4 piccolo device was reported.The piccolo was used off label in a patient under 700 grams.A more comprehensive assessment could not be performed as the device was not returned for analysis.A review of the measurements as reported from the field was performed.Per the sizing table in the instructions for use, arten600042307 version a, the correct size piccolo occluder for the measurements provided was a 5-2mm, the size of the initial device which was attempted to be implanted but was found to be too large for the size of the patient.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The cause of the reported event could not be conclusively determined.A capa was initiated for further investigation on the device migration, per internal procedures.Per the instructions for use, arten600042307 version a, "contraindications: weight < 700 grams at time of the procedure".
 
Event Description
On (b)(6) 2020, an 11 week 580 grams patient with a patent ductus arteriosus (pda) of the following dimensions: 3.5 mm diameter at pulmonary end and 6.0 mm diameter at the aortic end; length 8 to 10 mm underwent attempted implantation of a 5-2 amplatzer piccolo.The device was mis-sized too large and exchanged for a 4-4 amplatzer piccolo.There was some difficulty in getting the device in position, but ultimately the device was placed successfully within the intra-ductal position.Seven days post procedure creatinine increased and urine output decreased with evidence of aortic protrusion based on echocardiography doppler study.At 1-week post implant the device further migrated into the aorta with the aortic disc obstructing blood flow, possibly caused by spontaneous ductal constriction at the pulmonary end, that led to extrusion of the device posteriorly into the aorta.The infant was taken to the cardiac catherterization laboratory and underwent successful stent placement to relieve the aortic obstruction via the carotid artery.The infant recovered post-procedure and is doing clinically well.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PICCOLO OCCLUDER
Type of Device
OCCLUDER, PATENT DUCTUS, ARTERIOSUS
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10360254
MDR Text Key201551232
Report Number2135147-2020-00355
Device Sequence Number1
Product Code MAE
Combination Product (y/n)N
PMA/PMN Number
P020024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Other
Type of Report Initial,Followup
Report Date 12/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/03/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-PDAP-04-04-L
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age11 WK
-
-